A detailed history of New York State Common Retirement Fund transactions in Repligen Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 567,044 shares of RGEN stock, worth $80.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
567,044
Previous 495,770 14.38%
Holding current value
$80.8 Million
Previous $62.5 Million 35.03%
% of portfolio
0.11%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.79 - $167.35 $8.54 Million - $11.9 Million
71,274 Added 14.38%
567,044 $84.4 Million
Q2 2024

Jul 31, 2024

BUY
$120.0 - $182.95 $10 Million - $15.3 Million
83,746 Added 20.33%
495,770 $62.5 Million
Q1 2024

May 07, 2024

SELL
$170.78 - $208.42 $2.29 Million - $2.79 Million
-13,388 Reduced 3.15%
412,024 $75.8 Million
Q4 2023

Feb 01, 2024

SELL
$114.17 - $185.35 $2.02 Million - $3.28 Million
-17,676 Reduced 3.99%
425,412 $76.5 Million
Q3 2023

Nov 07, 2023

BUY
$138.78 - $176.51 $872,787 - $1.11 Million
6,289 Added 1.44%
443,088 $70.5 Million
Q2 2023

Aug 07, 2023

BUY
$138.42 - $180.31 $592,576 - $771,907
4,281 Added 0.99%
436,799 $61.8 Million
Q1 2023

May 02, 2023

BUY
$154.26 - $198.1 $339,680 - $436,216
2,202 Added 0.51%
432,518 $72.8 Million
Q4 2022

Jan 30, 2023

SELL
$162.42 - $220.56 $1.22 Million - $1.65 Million
-7,495 Reduced 1.71%
430,316 $72.9 Million
Q3 2022

Nov 08, 2022

BUY
$160.42 - $256.21 $457,517 - $730,710
2,852 Added 0.66%
437,811 $81.9 Million
Q2 2022

Aug 04, 2022

BUY
$140.68 - $188.02 $12.4 Million - $16.6 Million
88,151 Added 25.42%
434,959 $70.6 Million
Q1 2022

May 05, 2022

BUY
$161.19 - $257.96 $5.25 Million - $8.4 Million
32,566 Added 10.36%
346,808 $65.2 Million
Q4 2021

Feb 02, 2022

SELL
$247.59 - $304.47 $3.66 Million - $4.5 Million
-14,787 Reduced 4.49%
314,242 $83.2 Million
Q3 2021

Nov 02, 2021

BUY
$194.77 - $324.21 $6.78 Million - $11.3 Million
34,792 Added 11.82%
329,029 $95.1 Million
Q2 2021

Aug 02, 2021

BUY
$165.87 - $220.95 $5.97 Million - $7.95 Million
35,991 Added 13.94%
294,237 $58.7 Million
Q1 2021

May 11, 2021

BUY
$180.37 - $226.26 $17.1 Million - $21.5 Million
94,861 Added 58.06%
258,246 $50.2 Million
Q4 2020

Feb 08, 2021

SELL
$148.08 - $206.57 $3.1 Million - $4.33 Million
-20,939 Reduced 11.36%
163,385 $31.3 Million
Q3 2020

Nov 05, 2020

SELL
$122.51 - $158.27 $8.64 Million - $11.2 Million
-70,515 Reduced 27.67%
184,324 $27.2 Million
Q2 2020

Aug 07, 2020

BUY
$94.33 - $140.48 $2.86 Million - $4.27 Million
30,367 Added 13.53%
254,839 $31.5 Million
Q1 2020

May 06, 2020

BUY
$84.96 - $109.14 $5.27 Million - $6.76 Million
61,975 Added 38.14%
224,472 $21.7 Million
Q4 2019

Feb 05, 2020

SELL
$73.84 - $93.08 $105,369 - $132,825
-1,427 Reduced 0.87%
162,497 $15 Million
Q3 2019

Nov 07, 2019

SELL
$76.65 - $95.51 $637,728 - $794,643
-8,320 Reduced 4.83%
163,924 $12.6 Million
Q2 2019

Aug 09, 2019

BUY
$54.2 - $85.95 $433,708 - $687,771
8,002 Added 4.87%
172,244 $14.8 Million
Q1 2019

May 08, 2019

BUY
$49.45 - $62.8 $232,810 - $295,662
4,708 Added 2.95%
164,242 $9.7 Million
Q4 2018

Feb 08, 2019

SELL
$48.26 - $68.88 $1.75 Million - $2.5 Million
-36,239 Reduced 18.51%
159,534 $8.41 Million
Q3 2018

Nov 07, 2018

SELL
$46.8 - $58.97 $1.25 Million - $1.58 Million
-26,739 Reduced 12.02%
195,773 $10.9 Million
Q2 2018

Aug 10, 2018

BUY
$35.26 - $47.04 $5.48 Million - $7.31 Million
155,392 Added 231.51%
222,512 $10.5 Million
Q1 2018

May 10, 2018

BUY
$30.92 - $37.27 $255,646 - $308,148
8,268 Added 14.05%
67,120 $2.43 Million
Q4 2017

Feb 13, 2018

SELL
$32.53 - $38.92 $368,369 - $440,730
-11,324 Reduced 16.14%
58,852 $2.14 Million
Q3 2017

Nov 06, 2017

SELL
$36.98 - $46.06 $66,009 - $82,217
-1,785 Reduced 2.48%
70,176 $2.69 Million
Q2 2017

Aug 11, 2017

BUY
N/A
71,961
71,961 $2.98 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.